European Healthtech startup funding raised during September 2025.
In September 2025, 44 European Healthtech companies raised a combined €537M across 44 funding rounds, up 46.1% versus September 2024. UK led by capital raised, and BGF was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| ViCentra | Series D+ | Sep 2025 | €73M |
| NRG Therapeutics | Series B | Sep 2025 | €58M |
| MRM Health | Series B | Sep 2025 | €55M |
| AMSilk | Other | Sep 2025 |
| €52M |
| Cyted Health | Series B | Sep 2025 | €37M |
| Arthex Biotech | Series B | Sep 2025 | €32M |
| Sunrise | Other | Sep 2025 | €25M |
| Unmind | Growth/Late | Sep 2025 | €22M |
| TERN Group | Series A | Sep 2025 | €21M |
| Enhanced Genomics | Series A | Sep 2025 | €16M |
| Highlight Therapeutics | Other | Sep 2025 | €15M |
| RDS | Series A | Sep 2025 | €14M |
| Xampla | Series A | Sep 2025 | €14M |
| Serenis | Series A | Sep 2025 | €12M |
| Integra Therapeutics | Seed | Sep 2025 | €11M |
